What is the NOAEL for 3,3′-(1,4-Phenylene)bis[5,6-diphenyl-1,2,4-triazine]?
3,3′-(1,4-Phenylene)bis[5,6-diphenyl-1,2,4-triazine] has 51 NOAEL studies in the database. The lowest reported value is 48.5 % via oral in rat. Source: SCCS_vision_codex.
CAS 55514-22-2
3,3′-(1,4-Phenylene)bis[5,6-diphenyl-1,2,4-triazine] (CAS 55514-22-2) is a chemical substance. Key regulatory status: REACH registered, 2 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, SCCS, ECHA REACH.
CAS, identifiers, formula, and alternate names for the matched substance record.
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| Europe | - | https://ec.europa.eu/growth/tools-databases/cosing/index.cfm?fuseaction=search.simple |
| Personal care | - | https://ec.europa.eu/growth/tools-databases/cosing/index.cfm?fuseaction=search.simple |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 54 | mg/kg bw/day | - | inhalation | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 1000 | mg/kg/day | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 1000 | mg/kg/day | - | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| =48.5 | % | NOAEL | oral | rat | SCCS_vision_codex |
| =48.5 | % | NOAEL | oral | rat | SCCS_vision_codex |
| =48.5 | % | NOAEL | oral | rat | SCCS_vision_codex |
| =48.5 | % | NOAEL | oral | rat | SCCS_vision_codex |
| =54 | mg/kg bw/day | NOAEL | inhalation | - | SCCS_vision_codex |
| =54 | mg/kg bw/day | NOAEL | inhalation | - | SCCS_vision_codex |
| =54 | mg/kg bw/day | NOAEL | inhalation | - | SCCS_vision_codex |
| =54 | mg/kg bw/day | NOAEL | inhalation | - | SCCS_vision_codex |
| =80 | mg/kg bw | NOAEL | dermal | rat | SCCS_vision_codex |
| =80 | mg/kg bw | NOAEL | dermal | rat | SCCS_vision_codex |
| =80 | mg/kg bw | NOAEL | dermal | rat | SCCS_vision_codex |
| =80 | mg/kg bw | NOAEL | dermal | rat | SCCS_vision_codex |
| =464 | mg/kg bw/day | NOAEL | oral | rat | SCCS_vision_codex |
| =464 | mg/kg bw/d | NOAEL | oral | - | SCCS_vision_codex |
| =464 | mg/kg bw/day | NOAEL | oral | rat | SCCS_vision_codex |
| =464 | mg/kg bw/d | NOAEL | oral | - | SCCS_vision_codex |
| =464 | mg/kg bw/day | NOAEL | oral | rat | SCCS_vision_codex |
| =464 | mg/kg bw/d | NOAEL | oral | - | SCCS_vision_codex |
| =464 | mg/kg bw/day | NOAEL | oral | rat | SCCS_vision_codex |
| =464 | mg/kg bw/d | NOAEL | oral | - | SCCS_vision_codex |
| =485 | mg/kg/day | NOAEL | oral | rat | SCCS_vision_codex |
| =485 | mg/kg/day | NOAEL | oral | rat | SCCS_vision_codex |
| =485 | mg/kg/day | NOAEL | oral | rat | SCCS_vision_codex |
| =485 | mg/kg/day | NOAEL | oral | rat | SCCS_vision_codex |
| =1000 | mg/kg bw/day | NOAEL | - | - | SCCS_vision_codex |
| =1000 | mg/kg/day | NOAEL | - | - | SCCS_vision_codex |
| =1000 | mg/kg bw/day | NOAEL | - | - | SCCS_vision_codex |
| =1000 | mg/kg/day | NOAEL | - | - | SCCS_vision_codex |
| =1000 | mg/kg bw/day | NOAEL | - | - | SCCS_vision_codex |
| =1000 | mg/kg/day | NOAEL | - | - | SCCS_vision_codex |
| =1000 | mg/kg bw/day | NOAEL | - | - | SCCS_vision_codex |
| =1000 | mg/kg/day | NOAEL | - | - | SCCS_vision_codex |
| =1000 | mg/kg bw/day | NOEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| 464 | mg/kg bw/day | developmental toxicity | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 1000 | mg/kg bw/day | developmental toxicity | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 80 | mg/kg bw | irritation | dermal | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 48.5 | % | repeated dose toxicity | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 54 | mg/kg bw/day | repeated dose toxicity | inhalation | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 485 | mg/kg/day | repeated dose toxicity | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 485 | mg/kg/day | repeated dose toxicity | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 1000 | mg/kg bw/day | repeated dose toxicity | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 1000 | mg/kg/day | repeated dose toxicity | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 1000 | mg/kg/day | repeated dose toxicity | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 1000 | mg/kg/day | repeated dose toxicity | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 1000 | mg/kg/day | repeated dose toxicity | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 1000 | mg/kg/day | repeated dose toxicity | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 464 | mg/kg bw/d | reproductive toxicity | oral | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
Showing 50 of 51 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | 3,3'-(1,4-Phenylene)bis(5,6-diphenyl-1,2,4-triazine) | 700-823-1 | ECHA overview → |
EU Scientific Committee opinions tied to the matched substance.
| Opinion | Date | Conclusion | Max Conc. | Concerns |
|---|---|---|---|---|
| SCCS/1594/18 | 30 July 2018 | safe with restrictions | up to 5% | CMR 1B impurities NMP and hydrazine identified as SVHC - must be kept at trace levels; poor biodegradation; high octanol-water partition coefficient |
| SCCS/1556/15 | 13 July 2015 | safe with restrictions | 5% as UV filter | No systemic concern at 5%; secondary amine - potential nitrosamine formation; not for use with nitrosating agents; inhalation safety not assessed |
Same-CAS cosmetic ingredient record for cross-vertical context.
3,3′-(1,4-Phenylene)bis[5,6-diphenyl-1,2,4-triazine] has 51 NOAEL studies in the database. The lowest reported value is 48.5 % via oral in rat. Source: SCCS_vision_codex.
3,3′-(1,4-Phenylene)bis[5,6-diphenyl-1,2,4-triazine] appears on 2 regulatory/inventory lists including Europe, Personal care. Source: EPA CPDat.
Yes, 3,3′-(1,4-Phenylene)bis[5,6-diphenyl-1,2,4-triazine] is also indexed as a cosmetic ingredient under the name TriAsorB. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, EPA DSSTox, ECHA REACH, CosIng / Ingredients DB. All data traces to primary regulatory sources and is updated from official government databases.
3,3′-(1,4-Phenylene)bis[5,6-diphenyl-1,2,4-triazine] also appears in cosmetics databases.